Protective effects of Celsior in lung transplantation.
BACKGROUND
Celsior is a new preservation solution for heart transplants that recently has been shown also to improve protection of pulmonary grafts. As these data were obtained in isolated lung preparations, we sought to perform further tests with an in vivo model of allogeneic lung transplantation.


METHODS
The left lungs of 41 rats were either transplanted immediately after harvest (controls) or flushed with and cold stored in Celsior or the blood-based Wallwork solution for 5 or 12 hours. Lungs were then reperfused for 30 minutes, after which ligation of the contralateral pulmonary artery and bronchus made the recipient rat exclusively dependent on the transplanted lung. Assessment of preservation was made on functional (blood gases, pulmonary hemodynamics) and structural (dry-to-weight ratio, light microscopy, myeloperoxidase [MPO] content) end points.


RESULTS
The protective effects of Celsior were primarily manifest, once the contralateral lung had been functionally excluded, as a better preservation of oxygen tensions in the 5-hour storage experiments (416 +/- 52 mm Hg vs 406 +/- 59 mm Hg in controls [p = NS] and vs 239 +/- 34 mm Hg in Wallwork [p < 0.05 vs the 2 other groups]) and a smaller increase in pulmonary vascular resistance in the 12-hour storage experiments (10.2 +/- 4.1 mm Hg/mL/minute vs 3.2 +/- 1.1 mm Hg/mL/minute in controls [p = NS] and vs 23.1 +/- 4.3 mm Hg/mL/minute in Wallwork [p < 0.02 vs Celsior, p < 0.002 vs controls]). Survival was also longer in the 12-hour preserved Celsior group. Other end points were not significantly different between the two preservative solutions.


CONCLUSIONS
These data support the efficacy of Celsior as a flush-out and storage solution for pulmonary grafts. Given its previously documented ability to adequately preserve heart transplants, Celsior might provide a unified "solution" to thoracic organ preservation.
Xiong
L
L
Department of Cardiovascular Surgery, Hôpital Lariboisière, Paris.
Legagneux
J
J
Wassef
M
M
Oubenaïssa
A
A
Détruit
H
H
Mouas
C
C
Menasché
P
P
D000418:Albumins / Q000627:therapeutic use; D000704:Analysis of Variance; D000818:Animals; D002245:Carbon Dioxide / Q000097:blood; D002712:Chlorides / Q000627:therapeutic use; D015925:Cryopreservation; D004187:Disaccharides / Q000627:therapeutic use; D004573:Electrolytes / Q000627:therapeutic use; D005971:Glutamates / Q000627:therapeutic use; D005978:Glutathione / Q000627:therapeutic use; D006439:Hemodynamics / Q000502:physiology; D006639:Histidine / Q000627:therapeutic use; D016040:Lung Transplantation / Q000379:methods* / Q000502:physiology; D008297:Male; D008353:Mannitol / Q000627:therapeutic use; D019188:Organ Preservation Solutions / Q000627:therapeutic use*; D009929:Organ Size; D010100:Oxygen / Q000097:blood; D009195:Peroxidase / Q000032:analysis; D011422:Propionates / Q000627:therapeutic use; D020011:Protective Agents / Q000627:therapeutic use*; D011652:Pulmonary Circulation / Q000502:physiology; D051381:Rats; D017208:Rats, Wistar; D015996:Survival Rate; D014184:Transplantation, Homologous; D014655:Vascular Resistance / Q000502:physiology
D000418:Albumins; C088453:Celsior; D002712:Chlorides; D004187:Disaccharides; D004573:Electrolytes; D005971:Glutamates; D019188:Organ Preservation Solutions; D011422:Propionates; D020011:Protective Agents; C089639:Wallwork solution; D002245:Carbon Dioxide; D008353:Mannitol; D006639:Histidine; D009195:Peroxidase; D005978:Glutathione; D010100:Oxygen